me too waiting, getting bed sores, waiting so much.
Per the Minutes, the FDA emphasized its commitment to working with Titan and its partner, Braeburn Pharmaceuticals, to pursue a reasonable path to approval, and all parties agreed that seeking an indication in individuals stabilized on 8 mg/day or less of sublingual buprenorphine (SL BPN) may be a suitable approval pathway for Probuphine.
some of you know me, some don't, some don't give a shi$. My wife has been supportive, but we've had enough. Out today. My luck , it will turn around. I hope for you folks invested. Joe
Something eerie last couple of days. News appears to be imminent based on their last conference call. I've been holding for nearly three years, averaged in @ 1.89. I've felt from the beginning Probuphine and the medication (which has already been approved, not to mention accepted) is a segway (spelling unsure) to the golden goose ( method for transporting medication via an implant over a six month period, more, or less ), Pro N ? too much wine and too tired to google it lol. Night everyone. I'll read the bashers on this post in the am. Get up at 3am, coffee, gym , than work, for how long work is another story, IBM employee!
you're spot on my friend. That is why they picked a drug (already approved) and treatment that people have been known to abuse, call it a twofer. Not going to write anymore, those in the know / know. Night. on a side bar, sick of this message board. I have a lot of respect for many here ( especially baxter!
Brief and to the point. I would agree. Probuphine the golden egg. get a product already approved. Engineer and patent approved a delivery method. Pro Neura is the Goose that laid the golden egg!
When your shorting a stock, your broker will lend it to you. The stock comes from it's own brokerage account. At some point you must 'close' the short, buy back the shares, thus return them to your broker. On the transverse, the price rises, you buy back and lose money. My point if all shares owned had a sell figure ( even MM) short selling couldn't occur.
The practice is referred to as naked short selling. If we (who own shares), all shares owned had a sell price, anything, but all shares owned had a price to sell, MM couldn't short sell those. You should put what ever shares you own up for a sell at $100 a share. Now wouldn't that be a hell of a story if they sold. Me, personally having a tough time lately sifting through what we're obligated to see and trying to determine an outcome. Yes, there have been some contractual amendments between Brauburn and Tiatan, but hasn't been anything dramatic. They're not leaving. I wouldn't be surprised if some FDA approval, to some extent doesn't happen either this week, or next.
Sentiment: Strong Buy